Familial Alzheimer Disease
What's New
Last Posted: Mar 31, 2023
- Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease.
Qiao Min, et al. Annals of clinical and translational neurology 2023 0 - Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
Weston Philip S J, et al. Neurology 2017 0 (21) 2167-2175 - Alternative splicing in a presenilin 2 variant associated with Alzheimer disease.
Braggin Jacquelyn E, et al. Annals of clinical and translational neurology 2019 0 (4) 762-777 - Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE.
Romas Stavra N, et al. Archives of neurology 2002 0 (1) 87-91 - Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
Gao Ying, et al. Neurobiology of aging 2019 1 154-157 - A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease.
Hartl Daniela, et al. Molecular psychiatry 2018 7 - Polygenic risk scores in familial Alzheimer disease.
Tosto Giuseppe, et al. Neurology 2017 2 - Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
Weston Philip S J, et al. Neurology 2016 10 - Role of common and rare APP DNA sequence variants in Alzheimer disease.
Hooli B V, et al. Neurology 2012 4 (16) 1250-7 - Familial Alzheimer disease
From NCATS Genetic and Rare Diseases Information Center - Late-Onset Familial Alzheimer Disease
From NCATS Genetic and Rare Diseases Information Center - Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease.
Cai Guiqing, et al. Neurobiology of aging 2012 2 (2) 416-417.e3 - High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
Villemagne Victor L, et al. Archives of neurology 2009 12 (12) 1537-44 - The heritability of abstract reasoning in Caribbean Latinos with familial Alzheimer disease.
Johnson Beverly, et al. Dementia and geriatric cognitive disorders 2007 0 (6) 411-7 - Variability of age at onset in siblings with familial Alzheimer disease.
Gómez-Tortosa Estrella, et al. Archives of neurology 2007 12 (12) 1743-8 - Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte Lucia, et al. Archives of neurology 2006 11 (11) 1586-90 - Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement.
Rippon G A, et al. Neurology 2006 1 (1) 35-40 - Prevalence of pathogenic mutations in an Italian clinical series of patients with familial dementia.
Signorini S, et al. Current Alzheimer research 2004 8 (3) 215-8 - Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia.
Steinbart E J, et al. Archives of neurology 2001 11 (11) 1828-31
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 14, 2024
- Content source: